Skip to main content
Evolutionary Applications logoLink to Evolutionary Applications
. 2025 May 21;18(5):e70111. doi: 10.1111/eva.70111

Vertical Cancer Transmission via Asexual Fragmentation and Associated Cancer Prevalence

Jibeom Choi 1,2,
PMCID: PMC12093053  PMID: 40401264

ABSTRACT

While sexual reproduction is a general feature of animals, fissiparity and budding are relatively uncommon modes of asexual reproduction by which a fragment from a parent becomes an independent organism. Unlike unitary development, tumor cells can be included in the detached fragment destined to become offspring. Although fragmentation facilitates the vertical transmission of parental tumor cells to nascent progeny, this process requires significantly fewer cell replications than development from a zygote. The former is a risk factor for cancer, while the latter reduces oncogenic mutations during replication, indicating that two opposite effects of carcinogenesis are involved in fragmentation. If fragmentation can significantly reduce the number of cell replications for the development and a small portion of parental cancer is transmitted to the offspring during fragmentation, consecutive fragmentation across generations can gradually diminish the cancer risk of offspring, which I term fragmentational purging. On the other hand, consecutive fragmentation may aggravate the cancer risk of the progeny, a process of fragmentational accumulation. The model results imply that fragmentational purging does not necessarily guarantee the evolution of fragmentation, nor does fragmentational accumulation ensure its exclusion. Other relevant factors including juvenile susceptibility of sexual reproduction and loss of genetic diversity stemming from asexual reproduction can influence the selective advantage of fragmentation. Furthermore, owing to the common features of stemness and self‐renewal, the existence of pluripotent adult stem cells required for fragmentation could be coupled with elevated cancer risk. The model results across diverse parameters and the associated mathematical analyses highlight multifaceted evolutionary trajectories toward fragmentation. Further investigation of cancer‐suppression strategies that fragmentational animals employ could provide insights into regenerative medicine and cancer therapy.

Keywords: binary fission, budding, cancer, fissiparity, primordial stem cell

1. Introduction

As an outcome of the major transition in the history of life, metazoan multicellularity is characterized by the dependency of constituent cells on the organism and the division of labor (differentiation). For instance, a human pancreatic beta cell (unless it is cancerous) is specialized for the secretion of insulin and cannot persist when detached from the body. The conventional understanding of metazoan obligate multicellularity is that germ cell lineages monopolize the capability to transmit their genetic materials to the subsequent generations, referred to as the Weissmann barrier (Solana 2013). Somatic cells including the cancer cells, on the other hand, eventually perish when the host organism is deceased except for few eccentric cells such as HeLa cells (Masters 2002). However, some types of cancer can be transmitted from organisms to organisms (Ujvari et al. 2016). In humans, maternal cancer can be vertically transmitted to infants during pregnancy (transplacental cancer transmission) (Tolar and Neglia 2003). Cancer can be horizontally transmitted via canine coitus or biting between Tasmanian devils (Ujvari et al. 2016; Pearse and Swift 2006; Belov 2011). Transmission of tumors via surgical organ transplantation has been reported (Kauffman et al. 2002).

The less attended mode of reproduction is fissiparity, by which an organism is divided into parts and each part becomes an independent organism. As the fragments are composed of multiple cells, the cancer could be included in fragments and transmitted to the subsequent generation. Similarly, cancer cells of the parental organism could be incorporated into the offspring produced by asexual budding. As an evident example, Domazet‐Lošo et al. (2014) experimentally confirmed that transplanted tumors of Hydra can be transmitted to the offspring produced by the budding (Figure 1a). A higher migration rate of the Hydra tumor cells would facilitate the transmission of the tumor cells to the budding polyp. Another experimental result suggests that Hydra tumor cells might be vertically and iteratively transmitted across multiple generations (Tissot et al. 2024). Analogous processes of vertical tumor transmission in species that reproduce by fissiparity and budding can be envisaged (Figure 1b,c). For brevity, let fragmentation refer to fissiparity and budding. In this study, fragmentational purging refers to the reduction of the cancer cells in the mature progeny generated by fragmentation compared to cancer cells of the parental organism. If fragmentation elevates the proportion of cancer cells in the mature progeny, it is labeled as fragmentational accumulation (Definition 1 in Appendix S1).

FIGURE 1.

FIGURE 1

The modes of asexual fragmentation and possible mechanism of vertical cancer transmission. (a) The tumor in Hydra can be vertically transmitted to the progeny produced by budding (after Domazet‐Lošo et al. 2014). (b) Tumor cells in planaria performing transverse binary fission would be somatically transmitted to the subsequent generation. (c) Tumor cells in a detached arm of the starfish (fissiparity) will remain in the offspring.

As evidenced by retinoblastoma and other hereditary cancer syndromes, oncogenic mutations in the germ cells can affect the cancer risk of the offspring (Knudson Jr 1971). However, cancer cells themselves cannot be passed on to the offspring by sexual reproduction given that cancerous germ cells cannot form a functional zygote. On the other hand, development from the aggregation of the cells rather than a single zygote can significantly reduce the required cell replication number for maturation—the evident risk factor of carcinogenesis (Tomasetti and Vogelstein 2015). Such contrasting effects of fragmentation on cancer susceptibility pose a conundrum of whether fragmentation elevates or suppresses the susceptibility.

Another feature of the fragmentational (fissiparous or budding) species is the possession of pluripotent primordial stem cells (priSCs) after maturation. Conceptualized by Solana (2013), self‐renewing priSCs have both gametic and somatic potential whose inclusion into the germline generalizes the germline continuity established from the Weismann barrier (Solana 2013). It is speculated that priSCs, like germ cells or multipotent stem cells, exhibit a germline multipotency program (GMP) such as piwi or nanos (Solana 2013; Juliano et al. 2010). Notable examples of adult primordial stem cells (henceforth, APSCs) are planarian neoblasts and Hydra I‐cells (interstitial stem cells), both of which can produce diverse types of cells. Considering the fragmentational capability of the planarian and Hydra combined with the multipotency of priSCs, it is tantalizing to expect that possession of the APSCs could be the prerequisite of fragmentation. GMP‐expressing APSCs that are comparable to neoblasts and I‐cells are found in other fragmentational animals including starfish (Fujita et al. 2023; Magalhães et al. 2023), annelids (Álvarez‐Campos et al. 2024), sponges (Juliano et al. 2010), acoels (Hulett et al. 2023), and sea anemones (Miramón‐Puértolas et al. 2024). There is reliable evidence that there are APSCs in coral (López‐Nandam et al. 2023). Furthermore, APSCs will confer high regenerative capability as revealed in fragmentational animals (Table S1).

Despite the evident advantages of the APSCs, the development of the APSCs would be a double‐edged sword because they share multiple traits with cancer stem cells. Both types of cells can self‐renew and produce diverse differentiated cells. Due to such commonalities, cancer stem cells may originate from stem cells (Shackleton et al. 2009). Consistent with this reasoning, planarian neoblasts and Hydra I‐cells are likely to be implicated in tumorigenesis (Domazet‐Lošo et al. 2014; Voura et al. 2017; Van Roten et al. 2018; Boutry et al. 2023). In other words, APSCs may require a smaller number of driver mutations to become cancerous as they are already equipped with stemness and self‐renewal capability. Furthermore, GMP may play a critical role in cancer stem cells (Garcia‐Borja et al. 2024).

Distinct attributes of fissiparous or budding organisms including APSCs and vertical transmission of cancer cells to the offspring must be pivotal factors for cancer susceptibility and the evolution of cancer suppression. Specifically, how would features associated with fragmentation including fragmentation frequency, regeneration capability, or juvenile vulnerability influence the optimal strategy of cancer suppression? To investigate the effect of asexual fragmentation on cancer evolution, I built a graph‐theoretical pedigree framework illustrating different modes of sexual and asexual reproduction. During the lifetime of an organism in the proposed model, different types of cells accumulate mutation and proliferate, influenced by the level of cancer‐suppression capability.

The theoretical formulation based on evolutionary principles and examination of cancer susceptibility across diverse model parameters demonstrates the conditions that favor asexual fragmentation and how they affect cancer prevalence. This may explain the production of efficient tumor‐suppressing substances in numerous fragmentational marine organisms that have possible medical applications (Macedo et al. 2021). Furthermore, this study provides evolutionary insight into why comprehensive regeneration is inhibited in animals composed of highly differentiated cells. To my knowledge, no study to date has mathematically investigated the effect of vertical cancer transmission by fragmentation on cancer prevalence across multiple generations.

In this model, the cancer of multicellular animals (Metazoa) was taken into account. The plants were not considered because plant tumors are generally less lethal and caused by infections rather than spontaneous mutations (Doonan and Sablowski 2010).

2. Model Formulations

2.1. Cell Types and Organism Composition

Based on the degree of oncogenic mutations in a cell, three levels of cell states were postulated in this model—normal cells, defective cells, and cancerous cells. Defective cells possess certain oncogenic mutations though they are yet to be cancerous. Mutations in normal cells turn them into defective cells. Additional mutations make defective cells cancerous. As revealed in Figure 2a, normal cells are illustrated with bright spherical morphology, while defective cells are in darker colors. Cancer cells exhibit rumpled surfaces.

FIGURE 2.

FIGURE 2

Growth and mutation diagram of unitary development (sexual reproduction) used in this study. (a) The brightness of a cell illustrates whether the cell is normal. Darker colors imply the existence of oncogenic mutations. Round‐shaped and bright cells are normal; round‐shaped and dark cells are defective; rumpled and dark cells are cancerous. Once embryogenesis is finished, the blue hue indicates somatic cells excluding APSCs. The red hue is allocated to germ cells (sperms and eggs). For an organism containing APSCs, yellow cells illustrate APSCs. When such cells are absent, yellow cells illustrate PGCs. Weismann barrier in this study follows the generalized framework proposed by Solana (2013). Under this perspective, APSCs are included in the germline as mutations in them can be directly transmitted to the progeny. (b) Under the preformation and rudimentary priSC model (Solana 2013), gametic and somatic fates are determined during embryogenesis. A normal zygote establishes a blastula composed of normal cells. The zygote is illustrated with a yellow hue considering their totipotency. Similarly, yellow cells in the blastula have gametic potential. After embryogenesis, PGCs (yellow cells) can produce germ cells, while mutations in somatic cells (blue cells) cannot be transmitted to the offspring. As replication proceeds, normal PGCs and somatic cells become defective, and defective cells become cancerous (black downward arrows). Normal, defective, cancerous PGCs are assumed to produce normal, defective, cancerous germ cells, respectively (red leftward arrows). (c) In this study, the possession of the multipotent APSCs is the prerequisite for the fragmentation. APSCs have both gametic and somatic potential. The composition of somatic cells under this model is partially influenced by APSC composition with the coefficient θ (Equation (10)). (d) Same as (b) when the zygote is a defective cell. This organism does not have any normal cells. (e) Same as (c) when the zygote is a defective cell. (f) The explanation of the arrows used in (b)–(e). APSC, adult primordial stem cell; GMP, germline multipotency program; PGC, primordial germ cell; priSC, primordial stem cell.

Once embryonic development is finished, three categories of adult cells depending on their functions were postulated. Somatic cells including adult stem cells (except APSCs) or progenitor cells (except primordial germ cells) are illustrated with a blue hue. In other words, it is defined in this model that adult somatic cells cannot directly transmit their genetic material to the progeny via sexual reproduction (evolutionary bystanders). Normal cells that exhibit the GMP excluding the germ cells are described with a yellow hue. Under preformation model (Solana 2013), yellow cells after embryogenesis represent primordial germ cells (PGCs). On the other hand, yellow cells after embryogenesis represent PGCs and APSCs under unlimited priSC model (Solana 2013) such as neoblasts or I‐cells.

If developed from a normal zygote, all cells immediately after embryogenesis were assumed to be normal (Figure 2b,c). As replication proceeds, defective and cancerous cells arise. If developed from a defective zygote, all cells immediately after the embryogenesis were assumed to be defective (Figure 2d,e).

Let Πt, Ψt, and Γt denote the proportions of the normal, defective, and cancerous PGCs/APSCs in an organism at t, respectively (Figure 2b). Here, t is the number of cell replications, postulating that t=0 immediately after embryogenesis or fragmentation. Alternatively, t may represent the age (the degree of senescence) of an organism given that the replication rate is constant. As these values represent the proportions, Πt+Ψt+Γt=1 regardless of t. Likewise, Nt, Dt, and Ct represent the proportions of normal, defective, and cancerous somatic cells.

Based on the two‐hit hypothesis for tumorigenesis (Knudson Jr 1971), it was postulated that the proportion of the normal PGCs/APSCs monotonically decreases as they transform into defective PGCs/APSCs or cancerous cells grow faster than normal cells. The defective PGCs/APSCs in turn transform into the cancerous PGCs/APSCs. As such, the following differential equations can be formulated.

dΠtdt=μ1Πt (1)
dΨtdt=μ1Πtμ2Ψt (2)
dΓtdt=μ2Ψt (3)

where μ1 is the transition rate (determined by mutation rate and proliferation of each cell type) from normal to defective PGCs/APSCs, and μ2 is that from defective to cancerous PGCs/APSCs. The general solutions for these differential equations are

Πt=Π0expμ1t (4)
Ψt=Ψ0expμ2t+μ1Π0expμ1texpμ2tμ2μ1 (5)
Γt=1Ψ0expμ2tΠ0μ2expμ1tμ1expμ2tμ2μ1 (6)

The transition dynamics of the somatic cells have identical structures.

dNtdt=k1Nt (7)
dDtdt=k1Ntk2Dt (8)
dCtdt=k2Dt (9)

where k1 and k2 are parameters for somatic mutations that correspond to μ1 and μ2.

Frequent oncogenic mutations will elevate the transition rates (μ1, μ2, k1, k2). Consequently, the immunity and the functionality of the tumor‐suppression mechanism should influence the transition rates. The parameter I in this study represents such a combined cancer‐suppression capability. Although the oncogenic mutation is absent, the higher growth rate of cancer cells can make transition rates positive as the higher proportion of cancer cells results in a reduced proportion of normal and defective cells.

For an organism developed from a normal zygote, Π0Ψ0Γ0=N0D0C0=1,0,0. If developed from a defective zygote, Π0Ψ0Γ0=N0D0C0=0,1,0. The initial proportion of the PGCs/APSCs and somatic cells of an organism developed via fissiparity or budding is determined by the composition of the parental organism (Figure 3a,b), which will be explained later.

FIGURE 3.

FIGURE 3

Growth and mutation diagram of fragmentation used in this study. (a) A detached fragment (or bud) from a NU or NFn organism is composed of diverse types of cells with different oncogenicity. Following the detachment, the cells in the fragment replicate during which mutation arises. Fragmentation postulates the existence of adult primordial stem cells (APSCs) such as planarian neoblasts and Hydra I‐cells. (b) If the detached fragment originates from a DU or DFn organism, no normal cell is included in the fragment. (c) The number of cell replications to reach maturity would be different for unitary development and fragmentation. For unitary development, a single cell needs to replicate to establish a mature organism, hence the required number of the replication would be larger than that of the fragmentation (TU>TF). In addition, an organism produced via unitary development needs to go through the juvenile period which is vulnerable to predation and starvation. The survival risk and associated fitness reduction of juvenility are reflected in ΔV and ΔW. APSC, adult primordial stem cell; priSC, primordial stem cell.

A single zygote needs to repeatedly replicate to reach the cell number of the mature organism. In contrast, a fragment that contains multiple cells needs to replicate fewer times to reach the cell number of maturity. Accordingly, the time or the number of replications to reach maturity would be larger for unitary development compared to those of fragmentation (Figure 3c). Let TU and TF denote the number of replications (or equivalent to the time given that the replication rate is constant) required to reach maturity by unitary development and fragmentation, respectively. It was assumed in the model that TU>TF. Refer to the Section 3 for the simplified mathematical analysis.

As all metazoans can reproduce by unitary development (sexual reproduction or parthenogenesis) (Queller 2000; Grosberg and Strathmann 1998), the same argument was set in this model. Considering that parthenogenesis without sexual reproduction is not a common mode of reproduction in nature (Vakhrusheva et al. 2020), unitary development solely refers to the outcome of sexual reproduction in this study. A new organism can be established from a normal or defective zygote (Figure 4a). Let type NU denote the organisms originating from a normal zygote. Type DU refers to the organism developed from a defective zygote. All cells of DU organisms are either defective or cancerous.

FIGURE 4.

FIGURE 4

The modes of reproduction and population dynamics used in this study. (a) An NU organism can produce a normal zygote which will later become an NU offspring. An NU organism can also produce a defective zygote, becoming a DU offspring. If a progeny is established from a fragment detached from the NU parent, the progeny becomes an NF1 organism. (b) NF1 organism can produce NF2 offspring by fragmentation. The NU organism is the fragmentational ancestor of NF1, NF2, and other NFn organisms. Likewise, the DU organism is the fragmentational ancestor of DFn organisms where n refers to the number of consecutive fragmentations across generations. (c) The pedigree of the model. At the first generation (Gen. 1), all population was assumed to be composed of NU organisms. Owing to spatial limitations, N and D refer to NU and DU organisms, respectively. NU organisms can produce NU, DU, and NF1 organisms in the subsequent generation (Gen. 2). NFi and DFi organisms can produce NF(i + 1) and DF(i + 1) organisms, respectively, by fragmentation. In addition, NFi organisms, by sexual reproduction, can produce NU and DU organisms, while DFi organisms can only produce DU organisms by sexual reproduction. Based on the subpopulation size and fitness of each type, the population composition of the subsequent generation can be estimated. Red and black arrows indicate the unitary development via normal and defective zygotes, respectively. The blue arrow corresponds to the fragmentation.

Let ΠV, ΨV and, ΓV denote the proportion of normal, defective, and cancerous PGCs/APSCs of NU organisms at maturity, respectively. Note that the superscript V is not the numeric value representing the power. Rather, it is a categorical label representing the NU type. Specifically, ΠV=ΠTU and ΨV=ΨTU with Π0=1 (Equations (4), (5), (6)). In addition, ΓV=1ΠVΨV. For DU organisms, ΠW=0 and ΨW=ΨTU with Ψ0=1. Similarly, let NV and DV denote the proportion of normal and defective somatic cells of NU organisms at maturity. Under the preformation model lacking APSCs, NV=NTU and DV=DTU with N0=1.

Let θ denote the proliferability of APSCs (0θ<1), which influences the production of somatic cells, oncogenicity, and regenerative capability. If APSCs that can generate the somatic cells are present, the composition of the somatic cells at maturity is influenced by the parameter θ (Figure 2c,e).

NVDV1NVDV=θΠVΨV1ΠVΨV+1θNTUDTU1NTUDTU (10)

which indicates that the composition of APSCs (ΠV, ΨV, ΓV) affects the composition of somatic cells at maturity (NV, DV). Using such relations, the somatic cell composition of DU organisms under an unlimited priSC model can be similarly described.

Higher APSC proliferability was assumed to confer higher regenerative capability that alleviates the damage of the physical trauma. As a trade‐off, higher APSC proliferability is associated with higher transition rates of APSCs (μ1, μ2) based on the fact that proliferation is linked to tumorigenesis (Jacqueline et al. 2017; Ratajczak et al. 2018; Cho et al. 2024). Consequently, the transition rates are primarily determined by the cancer‐suppression capability (0<I<1) combined with APSC proliferability and biased replication fidelity (s).

k1=I (11)
μ1=1+θ2sηI (12)

Here, ηI is the baseline transition rate determined by the cancer‐suppression capability I. As a higher cancer‐suppression capability reduces mutation rates, ηI is monotonically decreasing against I. Refer to Equation (S5) for its details. While I is the major contributor to cancer suppression, there could be supplementary APSC‐specific or somatic‐cell‐specific mechanisms of tumor suppression such as differential gene expression or allocation of quiescent subpopulation (Van Roten et al. 2018; Cheung and Rando 2013; Mihaylova et al. 2018). s and 2s represent such disproportionate replication fidelity in PGCs/APSCs and somatic cells. If s=0.5, for instance, the mutation in somatic cells is suppressed at the cost of elevated mutations in PGCs/APSCs. In this model, five values of s were evaluated: 0.5, 0.75, 1, 1.25, 1.5. Furthermore, higher APSC proliferability elevates mutation risk (Jacqueline et al. 2017; Ratajczak et al. 2018; Cho et al. 2024), implemented in the term 1+θ of Equation (12). For organisms that lack APSCs, θ=0.

Stemming from genomic instability or haploinsufficiency, inactivation of an allele of tumor‐suppression genes can facilitate the subsequent genetic alterations required for carcinogenesis (Smilenov 2006; Konishi et al. 2011). As such, transition rates from defective to cancerous cells were assumed to be higher than those from normal to defective cells. Specifically, k2=1.5k1 and μ2=1.5μ1.

Regardless of the organism types, let NP, DP, and CP denote proportions of the normal, defective, and cancerous somatic cells at maturity, respectively. Likewise, ΠP, ΨP, and ΓP are the proportions of the normal, defective, and cancerous PGCs/APSCs at maturity, respectively. The inherited composition of the progeny produced by fragmentation at birth (ΠF,ΨF,ΓF) is

ΠFΨFΓF=1f1ΠP+f2ΨP+f3ΓPf1ΠPf2ΨPf3ΓP (13)

Composition of somatic cells (NF, DF, CF) after fragmentation follows the identical relation.

NFDFCF=1f1NP+f2DP+f3CPf1NPf2DPf3CP (14)

Three nonnegative parameters f1, f2, f3 represent the vertical transmission degree of normal, defective, and cancerous cells. If cancerous cells are highly mobile so that they are readily included in the dividing fragment as in the case of Pelmatohydra robusta (Domazet‐Lošo et al. 2014), f3 would not be significantly smaller than f1.

The fitness of each organism (ω) is determined by the composition of the somatic cells, cancer‐suppression capability, and the cost of the damage (physical trauma such as injury or predator attacks).

ω=ω0+αNNPε+αDDPε+αCCPεχθgI (15)

where ω0 is the baseline fitness, χθ is the effect of external damage (trauma), and gI is the cost of sustaining the cancer‐suppression capability. αN, αD, and αC are coefficients that determine how cell composition influences fitness. As a higher proportion of normal cells and a lower proportion of cancer cells will elevate fitness, it was postulated that αNαDαC. The power ε (exponent for NPε=NPε) applied to NP, DP, and CP demonstrates the aggressive and lethality of cancer. As NP, DP, and CP are proportional values such that NP+DP+CP=1 and 0NP,DP,CP1, the increase in CP results in a corresponding decrease in NP or DP. As a simple example, compare two cases of somatic composition x1=1,0,0 and x2=0.9,0,0.1. Here, x1 depicts an organism purely composed of normal somatic cells. If 10% of the normal cells become cancerous, it is equivalent to x2. Let us calculate αNNPε+αDDPε+αCCPε for αN=1 and αC=0. If ε=1, this value is 1 for x1, and 0.9 for x2. If ε=2, on the other hand, the value is still 1 for x1, but it becomes 0.81 (= 0.92) for x2. In general, values of ε higher than 1 are associated with aggressiveness or fatality of cancer as a slight increase in CP leads to a significant drop in total fitness. In simulation models, I assigned the values of ε from 1 to 2 depending on cancer fatality (Table S2) where higher ε implies that cancer is life‐threatening to that species.

χθ is the fitness reduction due to the external damage that is dependent on the APSC proliferability (θ). Specifically,

χθ=τδ1θ2 (16)

where τ is the frequency of the external damage and δ is the severity of the damage in each traumatic event. Higher APSC proliferability reduces the expected damage owing to the high regenerative capability, reflected by 1θ2.

As in the case of the tumor‐suppression gene p53, higher cancer‐suppression capability enhances the replication fidelity while overall fitness is accordingly reduced (Jacqueline et al. 2017; Tyner et al. 2002). Hence, gI=c0I2 for a specific nonnegative coefficient c0.

2.2. Modes of Reproduction and Population Dynamics

The label NF1 indicates that an organism is reproduced by the fragmentation of an NU organism (Figure 4b). If an NF1 organism produces an offspring by fragmentation, the offspring is NF2. In general, the NFn organism produces NF(n + 1) organisms by fragmentation. For NFn organisms, the fragmentational ancestor is an NU organism. In other words, fragmentational ancestor is defined as the most ancestral organism in the pedigree that initiated the repeated fragmentation. Here, n denotes the number of consecutive fragmentations across generations. DFn organisms can be analogously defined whose fragmentational ancestor is a DU organism.

NFn organisms can produce normal or defective zygotes. Hence, the NFn organisms can produce NU or DU organisms by sexual reproduction (unitary development). In contrast, it was assumed that DFn organisms can only produce defective zygotes as they do not possess normal cells. Thus, all progeny of DFn organisms produced by unitary development are DU organisms.

In each reproductive event of an organism, ϕ is the probability that the organism reproduces by fragmentation. Accordingly, 1ϕ is the probability to reproduce sexually. Let Vj and Wj denote the subpopulation size of the NU and DU organisms at the j‐th generation, respectively. Likewise, Zi,j and Qi,j are the subpopulation size of NFi and DFi organisms at the j‐th generation.

As previously explained, the proportions of the normal, defective, and cancerous PGCs/APSCs of NU organisms at maturity are ΠV, ΨV, and ΓV. It was assumed that cancerous germ cells cannot develop into an organism by unitary development. In each reproduction by unitary development, a normal gamete will be more likely to succeed in reproduction compared to a defective or cancerous gamete. Therefore, the contribution of the NU organisms in the j‐th generation to the subpopulation size of the NU organisms in the (j + 1)‐th generation is proportional to

1ϕr1ΠVr1ΠV+r2ΨV+r3ΓVVjωV (17)

where ωV is the fitness (reproductive success) of an NU organism calculated by Equation (15). Again, the superscript V is not a numeric value representing the power: it is the label for NU organisms. r1, r2, r3 reflect the differential success rates in the fertilization of normal, defective, and cancerous germ cells.

For NFi organisms, their contribution to the subpopulation size of NU organisms in the subsequent (j + 1)‐th generation is proportional to

1ϕr1ΠiZr1ΠiZ+r2ΨiZ+r3ΓiZHjZi,jωiZ (18)

where ΠiZ, ΨiZ, and ΓiZ are the proportions of normal, defective, and cancerous PGCs/APSCs of mature NFi organisms, respectively. Here, as in the case of ΠV, the superscript Z is assigned to NFi organisms. ωiZ is the fitness of an NFi organism, which is multiplied by Hj, the effect of genetic diversity (refer to Equation (22)). Consequently, the untransformed subpopulation size of NU organisms in the (j + 1)‐th generation is

Vj+1*=ΔV1ϕVjωVU1V+Hji=1j1Zi,jωiZU1,iZ (19)

where

U1V=r1ΠVr1ΠV+r2ΨV+r3ΓV (20)
U1,iZ=r1ΠiZr1ΠiZ+r2ΨiZ+r3ΓiZ (21)

U1V demostrates the probability that an NU organism produces a normal zygote. U1,iZ is the same as U1V for NFi organisms. 1ϕ reflects the probability that an organism attempts to reproduce by unitary development. ΔV is the survival probability of the NU organisms' juvenile period (0<ΔV<1) (Figure 3c). For instance, echinoderm larvae would be exposed to the risk of predation and death due to their small size and immature mobility. ΔW is the same as ΔV for DU organisms. Organisms produced by the fragmentation do not experience such juvenile susceptibility in this model. If a cancerous germ cell succeeds in fertilization, the embryo cannot develop. Note that DU and DFi organisms cannot produce NU offspring because they do not possess normal germ cells.

The fragmentation produces clonal offspring, and the existence of multiple clonal organisms will make them susceptible to infectious disease and cancer (Thomas et al. 2019). Let Hj denote the coefficient that describes the fitness reduction due to the loss of genetic diversity. Given that ρj is the proportion of the NFi and DFi organisms at the j‐th generation,

Hj=b0+1b01ρj14 (22)

for 0<b0<1. The concavity of Hj against ρj explains that a smaller proportion of clones in the population has a negligible effect on population fitness. However, a higher proportion of clones drastically reduces the fitness of NFi and DFi organisms (0Hj1). Lower values of b0 are associated with the pronounced fitness reduction stemming from the genetic homogeneity (Figure S1).

The actual subpopulation size of the NU organisms at the subsequent generation (Vj+1) should consider the effect of the fluctuations in total population on the untransformed population size (Vj+1*) which will be explained later.

All organisms in a generation are expected to possess defective germ cells. Hence, they can produce DU organisms by unitary development. By the same reasoning as Vj+1* was deduced,

Wj+1*=ΔW1ϕVjωVU2V+WjωWU2W+Hji=1j1Zi,jωiZU2,iZ+Hji=1j2Qi,jωiQU2,iQ (23)

where the asterisk implies that it is an untransformed subpopulation size. The detailed derivation processes are provided in Appendix S1.

NF1 organisms in the (j + 1)‐th generation are produced by NU organisms in the j‐th generation by asexual fragmentation (Figure 4).

Z1,j+1*=ϕVjωV (24)

Similarly, NF(i + 1) organisms in the (j + 1)‐th generation are produced by NFi organisms in the j‐th generation by asexual fragmentation.

Zi+1,j+1*=ϕHjZi,jωiZ (25)

Likewise, DFi organisms satisfy the following equations.

Q1,j+1*=ϕWjωW (26)
Qi+1,j+1*=ϕHjQi,jωiQ (27)

By the aforementioned relations, the total untransformed population size of (j + 1)‐th generation is determined.

Pj+1*=Vj+1*+Wj+1*+i=1jZi,j+1*+i=1j1Qi,j+1* (28)

Considering the environmental capacity and to avoid the abrupt change in population size, it was assumed that the ratio of population size at the (j + 1)‐th and j‐th generation is bounded between 0.9391 to 1.08. These bounds are determined by the specific logistic function (Θ, Equation (S7)) designed to prevent rapid fluctuations of populations (Figure S2). The actual subpopulation size at the (j + 1)‐th generation was calculated by multiplying the untransformed subpopulation size by ΘPj+1*/Pj. For example, Vj+1=ΘPj+1*/PjVj+1* and Wj+1=ΘPj+1*/PjWj+1*. The sum of the individual organisms' fitness at the 30th generation was used as the optimization index of the reproduction strategy. The variables are explained in Table 1.

TABLE 1.

The explanation of the major variables and abbreviations used in this study.

Variable or abbreviation Description
priSC Primordial stem cells (e.g., planarian neoblasts, Hydra I‐cells, 4d lineage of annelids and mollusks, the inner cell mass of mammalian embryo (Solana 2013))
APSC Adult primordial stem cell
PGC Primordial germ cell
GMP Germline multipotency program
Πt, Ψt, Γt The proportions of normal, defective, and cancerous PGCs/APSCs of an organism after t times of cell replications
Nt, Dt, Ct The proportions of normal, defective, and cancerous somatic cells of an organism after t times of cell replications
μ1, μ2, k1, k2 The transition rates that determine the transformation of normal cells into defective cells (μ1, k1) and the transformation of defective cells into cancerous cells (μ2, k2). μ1, μ2 represent the transition rates of PGCs/APSCs, and k1, k2 represent the transition rates of somatic cells. In addition to mutation rates, the differential growth rate of each cell type can affect the transition rates
ϕ
The probability that the organism reproduces by fragmentation in each reproductive attempt
Vj, Wj The subpopulation sizes of the NU and DU organisms at the j‐th generation, respectively
Zi,j, Qi,j The subpopulation sizes of NFi and DFi organisms at the j‐th generation
Vj*, Wj*, Zi,j*, Qi,j* The untransformed subpopulation sizes of Vj, Wj, Zi,j, Qi,j, respectively. Applying the effect of total population fluctuation (Equation (S7)) determines the actual subpopulation size
ωV, ωW, ωiZ, ωiQ The fitness of NU, DU, NFi, DFi organisms, respectively. Here, the superscripts are not numbers, but labels
θ
The proliferation index of APSCs which influences the production of somatic cells, cancer risk, and regenerative capability
ε
The parameter (power) that determines the fatality of cancer. A small increase in cancer proportion results in significant fitness reduction if ε is high
TU, TF The numbers of cell replications required to obtain maturity for unitary development and fragmentation, respectively
ΔV, ΔW The survival rates of NU and DU juvenile organisms developed from the zygote, respectively
f1, f2, f3 The degrees of vertical transmission via fragmentation for normal, defective, and cancerous cells, respectively
r1, r2 The functionality of normal and defective germ cells that determines their probability of fertilization

Using the principles of linear algebra, we can mathematically expect how consecutive fragmentations influence the proportion of the cancer cells in the progeny. Suppose that f3>maxf1expμ1TFf2expμ2TF holds. In this condition, consecutive fragmentation results in a higher proportion of offspring (Propositions 1, 2 in Appendix S1), and fragmentational purging is not allowed (Corollary 1 in Appendix S1). This implies that the higher propensity of tumor cell transmission via fragmentation (f3), higher transition rates (μ1,μ2), and longer time required for the maturity after fragmentation (TF) are likely to induce fragmentational accumulation. On the other hand, if f1expμ1TF>maxf2expμ2TFf3, the proportion of cancerous APSCs in NFn organisms converges to a certain nonnegative value as fragmentation is repeated (Proposition 1). If f2expμ2TF>f3, the same argument applies to DFn organisms (Proposition 2). Proof, conditions, and specific examples (Examples S1, S2) of the mathematical arguments are provided in Appendix S1.

2.3. Computational Analysis

To analyze the evolutionary dynamics of the diverse fissiparous or budding organisms, models under different sets of parameters were tested. There are three types of models in this study—FRPG, FRAC, BINF. Fragmentation under FRAC (fragmentational accumulation) models elevates the proportions of cancerous cells of progeny. Therefore, cancers of organisms accumulate through consecutive fragmentations. Fragmentation under FRPG (fragmentational purging) models reduces the proportions of cancerous cells of progeny. While fragmentation of FRPG and FRAC assumes asymmetric fragmentation or budding, BINF (binary fission) models illustrate binary fission inspired by planarian fission assuming (nearly) homogeneously distributed tumor cells. Accordingly, binary fission in this model postulates f1=f2=f3 implying that all cells are equitably distributed into two fragments. Unlike asymmetric fragmentation or budding, there is no parent–offspring relationship after binary fission: each half becomes the offspring. Thus, two offspring are produced by binary fission rather than a single nascent offspring from budding or asymmetric fragmentation. Since the fragment from binary fission has the same cell composition as the parent, the mature organism should have a higher proportion of cancer cells than the parent (Corollary 2 in Appendix S1). As such, for binary fission accompanied by equitable cell distribution, consecutive binary fission elevates the proportions of the cancers across generations, similar to FRAC models.

FR or UD were appended to the model names depending on which strategy is fitness‐maximizing, where FR and UD stand for fragmentation and unitary development, respectively. For instance, the model name FRAC‐UD implies that consecutive fragmentation elevates cancer cell composition and unitary development is the fitness‐maximizing strategy. The dynamics of the seven models were examined by changing the parameters including juvenile survival probability (ΔV, ΔW), frequency (τ) and severity (δ) of external damage, the effect of genetic diversity (b0) (Table S2). In each model, the inactivation of the fragmentation (ϕ=0) implies the absence of the APSCs (θ=0). In such cases, μ1 and μ2 (Equations (1), (2), (3), (4), (5), (6)) solely represent the transition rates of PGCs.

For each model, five strategies of biased replication fidelity (s is either 0.5, 0.75, 1, 1.25, 1.5) were tested. By changing the values of s in Equations (11) and (12), somatic cells can be intensively protected from the mutation at the cost of elevated mutation of PGCs/APSCs and vice versa. APSC proliferability (θ) was varied from 0.1 to 0.7 in steps of 0.1 for each model. Fitness surfaces obtained from different levels of fragmentation prevalence (ϕ) and cancer‐suppression capability (I) were recorded, along with cancer prevalence.

FRPG‐FR model postulates a high degree of fragmentational purging by setting f1,f2,f3=5,1,0.5 and TU,TF=35,15. NU and ND organisms suffer fitness reduction (e.g., predation, malnutrition) during the juvenile period that NFi and DFi organisms do not need to sustain (ΔV,ΔW=0.7,0.5). This model would be pertinent to species whose budding is formed at tumor‐free regions with long and susceptible larval periods. Other parameters and details are available in the MATLAB codes.

Throughout diverse values of APSC proliferability in this FRPG‐FR model, the adoption of fragmentation is advantageous for survival (Video S1). The most favorable strategy is to perform fragmentation more frequently than unitary development (ϕ>0.5) with maximized APSC proliferability (θ=0.7) and APSC replication fidelity (s=1.5). As fragmentation became frequent, the corresponding optimal cancer‐suppression level was released (Figure 5a, Video S1). It can be interpreted that prevalent fragmentational purging works as a cancer‐suppression mechanism. Hence, there is less need to sustain the high level of physiologically costly cancer‐suppression level when fragmentation is prevailing.

FIGURE 5.

FIGURE 5

The results of FRPG‐FR and FRPG‐UD model when maximal fitness is achieved. (a) The overall fitness of the populations adopting different reproductive strategies was evaluated across the parameters of the FRPG‐FR model (Video S1). The translucent surface illustrates the overall fitness at the given parameters. Blue dots on the surface mark the maximized fitness for each fragmentation value (ϕ) with the corresponding optimal cancer‐suppression capability (immunity, I). The red dot on the surface represents the globally maximal fitness on the surface. The black dot represents the maximal fitness when fragmentation is inhibited (ϕ=0). The projections of maximal points are also marked on the xy‐plane. The globally maximal fitness under θ=0.7 and s=1.5 outcompetes the globally maximal fitness under other conditions. Such a set of parameters postulates the higher APSC proliferation (θ) and APSC replication fidelity (s). Note that optimal immunity in each fragmentation value decreases as fragmentation value increases, as shown by the trend of projected blue markers. (b) The overall fitness of the populations under the FRPG‐UD model was evaluated (Video S2). Note that the configurations of axes are different from (a). Maximal fitness was obtained when the organism did not perform fragmentation with concentrated mutation protection on somatic cells (s=0.5). As it was assumed that APSCs are absent in populations that exclusively perform sexual reproduction, θ does not influence the fitness of populations lacking APSCs. (c) The cell composition of the NU and NFn organisms with immunity of optimal fitness under the FRPG‐FR model (the red marker in (a)). Colors represent the proportion of normal, defective, and cancerous cells from the PGC/APSC population (yellow hue) and somatic cells (blue hue). Note that the y‐axis is in the log scale. The composition of the NFn organism was marked with the number of consecutive fragmentations (n), while the NF0 represents the NU organism. Repeated fragmentations reduce the proportions of the cancerous cells across the generations (fragmentational purging). (d) The average cancer prevalence in the population under the conditions that are marked in (a). The blue, red, and black markers in this panel match the conditions of those markers in (a). A higher rate of fragmentation leads to lower average cancer prevalence. (e) Same as (d) for the FRPG‐UD model of (b). The light blue markers imply that fitness on that condition is lower than the fitness obtained from unitary development. (f) Color legend for panel (c).

For the FRPG‐UD model, the organisms are less inflicted by cancer because the exponent of the composition‐to‐fitness function (ε in Equation (15)) was modified from ε=2 of the FRPG‐FR model to ε=1.1. By diminishing the exponent, an increase in cancer cells becomes less detrimental to organismal fitness. Accordingly, the advantage of fragmentational purging becomes less prominent. The external damage is less severe (τδ=0.3,0.1 in Equation (16)), while the loss of genetic diversity imposes higher fitness reduction in this model (b0=0.1 in Equation (22)). Risk during the juvenile period (ΔV, ΔW) and fragmentational values (f1, f2, f3) were modified as well. As a result, though consecutive fragmentation lowers the cancer composition (fragmentational purging), the optimal strategy is to exclusively perform sexual reproduction (Figure 5b). This result indicates that fragmentational purging does not ensure the adoption of fragmentation as an evolutionarily stable strategy. Furthermore, as a general tendency, higher values of fragmentation in FRPG models result in lower cancer prevalence under a wide range of conditions (Figure 5d,e).

On the other hand, consecutive fragmentation elevates cancer composition in the FRAC‐UD model. Under this model, it is optimal to exclude fragmentation with concentrated mutation protection on somatic cells (Figure 6b). By adopting exclusive sexual reproduction, the cancer prevalence can be suppressed to low values compared to those obtained from the corresponding fragmentation‐involved strategies (Figure 6e).

FIGURE 6.

FIGURE 6

The results of FRAC‐FR and FRAC‐UD model when maximal fitness is achieved. (a) Under the FRAC‐FR model (Video S3), performing fragmentation with maximal APSC proliferability and elevated replication fidelity in APSCs resulted in globally maximal fitness. (b) Under the FRAC‐UD model (Video S4), sexual reproduction without fragmentation resulted in globally maximal fitness. (c) The cell composition of the NU and NFn organisms under immunity of optimal fitness from the FRAC‐FR model (the red marker in (a)). Unlike FRPG models, the proportion of cancer rises as consecutive fragmentation is repeated. (d) The average cancer prevalence in the population under the conditions that are marked in (a). Due to the fragmentational accumulation, the higher fragmentation rates induce a higher cancer prevalence. (e) The average cancer prevalence in the population under the conditions that are marked in (b).

If there is a significant survival risk during the juvenile period and external damage is severe, fragmentation can be selected for though consecutive fragmentation raises the cancer composition, as evidenced by results of the FRAC‐FR (Figure 6a). Unlike FRPG models, higher fragmentation in FRAC models leads to higher cancer prevalence at the optimized cancer‐suppression level (Figure 6d,e).

Different conditions were implemented in BINF‐FRa and BINF‐FRb. BINF‐FRa is characterized by the prevalent external damage and the low survival rate of juvenile organisms established from unitary development. Additionally, it was assumed that loss of genetic diversity stemming from asexual reproduction imposes mild fitness reduction (b0=0.7). As a result, fragmentation is favored in this model (Video S5).

Due to the modified fitness function (changes in αN, αD, αC, ε of Equation (15), Table S2), the cancer does not dramatically reduce organismal fitness under the BINF‐FRb model. In this model, fragmentation is favored with concentrated replication fidelity on APSCs (Video S6). Results of BINF‐FRa and BINF‐FRb illustrate two possible evolutionary pressures for the adoption of binary fission.

Reduced risk during juvenility, prominent vulnerability resulting from the loss of genetic diversity, and infrequent external damage lead to dominance of unitary development excluding fragmentation, as supported by BINF‐UD (Video S7). All model results are summarized in Videos [Link], [Link], [Link], [Link], [Link], [Link], [Link], and specific model parameters are presented in Table S2.

3. Discussion

Although fragmentation (including budding) is not a common mode of reproduction in animals, a comparative analysis of cancer susceptibility and cancer suppression therein would expand our understanding of cancer from an evolutionary perspective. Considering the existence of the APSCs, verified or presumptive, in fragmentational species, the APSCs could be the prerequisite for performing fissiparity or budding. The APSCs are associated with high regenerative capability, while sharing multiple essential traits with cancer stem cells.

Two counterbalancing effects of carcinogenesis are involved in the reproduction by fragmentation. Although fragmentation explicitly delivers the parental somatic cancer cells to progeny, it can reduce the number of cell replications (and accordingly time) required to reach maturity. To simplify the situation, suppose that all cells are viable until maturity. Given that the cell number at maturity is NM, a zygote and its progeny cells need to replicate log2NM times to reach maturity. Given that the offspring contains rNM cells after fragmentation (0<r0.5), the required number of the replication is log2rNM. For example, if a mature organism is composed of 1024 (= 210) cells, then a zygote needs to replicate 10 times to reach that size. On the other hand, if a detached fragment contains 128 (= 27 where r=1/8) cells, each cell needs to divide 3 times. The reduction in replication number culminates in binary fission (r=0.5). Under this simplified framework, only a single replication of each cell suffices to establish an integral organism after binary fission. Even though binary fission assuming equitable cell distribution will intensify the cancer risk of offspring (Corollary 2), the time required for maturation after fission will be substantially reduced than the maturation from a zygote (Ivankovic et al. 2019; Stocchino and Manconi 2013). By all means, this postulation does not consider the lifespan of cells and the precise developmental process toward maturity. Nonetheless, it is indisputable that offspring produced via fragmentation benefit from fewer cell replications or shorter maturation periods (implemented in the models by TU, TF, ΔV, ΔW). As the number of stem cell replications is an evident risk factor for cancer (Tomasetti and Vogelstein 2015), fragmentation may reduce the offspring's cancer risk.

How cancerous or defective cells are transmitted to progeny combined with the reduced number of cell replications determines whether fragmentation elevates the cancer prevalence of the progeny. Depending on such conditions, consecutive fragmentation may suppress or raise the cancer prevalence (fragmentational purging or accumulation) as investigated in Propositions 1, 2, and Corollary 1. Mathematical analyses imply that a lower rate of vertical cancer transmission (f3) and the reduced number of cell replications after fragmentation (TF) are likely to induce fragmentational purging. Frequent fragmentational purging functions to suppress cancer so that the burden of physiological cancer suppression is relieved (Figure 5a, Video S1). However, fragmentational purging does not ensure the adoption of fragmentation (FRPG‐UD), nor does fragmentational accumulation necessarily prevent fragmentation (FPAC‐FR). Despite the fragmentational accumulation, a low survival rate during juvenility (ΔV, ΔW) facilitates the adoption of fragmentation as shown in FRAC‐FR and BINF‐FRa models. In contrast, the benignity of the tumor was postulated in the FRPG‐UD model, implying that fragmentational purging may not be a merit if the tumor is not a serious threat.

Another consequence of the fragmentation is the loss of genetic diversity. Sexual reproduction allows the production of offspring with diversified traits, endowing adaptive advantage under changing environments (Becks and Agrawal 2012; Bürger 1999). Deleterious mutations can be eliminated during the course of sexual reproduction (Muller 1964). Particularly, sexual reproduction could confer protection from horizontally transmissible cancers (Thomas et al. 2019). This factor was implemented in the model by changing the coefficient b0 in Equation (22).

A certain Hydra species, Hydra oligactis and P. robusta , spontaneously develop tumor (Boutry et al. 2023), but not all progeny budded from tumoral parents have transmitted tumor (Boutry et al. 2022). Even in the presence of tumors, they still can produce their progeny sexually or asexually (Tissot et al. 2024; Domazet‐Lošo et al. 2014; Boutry et al. 2022). Consecutive vertical cancer transmission of H. oligactis appears to elevate the cancer proportion of the offspring (Tissot et al. 2024), comparable to fragmentational accumulation. Furthermore, the bearing of tumors may alter the reproductive strategy of the host Hydra such as reproductive age or budding rates (Tissot et al. 2024; Boutry et al. 2022). Similarly, tumoral planaria still can reproduce asexually (Lange 1966).

Consecutive fragmentation mediated by binary fission postulating equal distribution of cells (f1=f2=f3) is expected to elevate cancer composition throughout generations (Corollary 2). Despite this drawback, results from BINF‐FRa and BINF‐FRb illustrate possible evolutionary pressures for adopting binary fission. In both models, maximal fitness is achieved when APSCs are strongly protected from mutation at the cost of somatic cell mutation risk. In accordance with this finding, stem cells of Schmidtea mediterranea are selectively protected from carcinogenesis (Van Roten et al. 2018; Mihaylova et al. 2018). However, within the same species of S. mediterranea , different strains exhibit different modes of sexual and asexual reproduction strategies (Zayas et al. 2005). Moreover, exposure to cadmium has different effects on planarian species. For example, S. mediterranea is resistant to cadmium‐induced carcinogenesis, while Dugesia dorotocephala and Dugesia tigrina are vulnerable (Van Roten et al. 2018). While it was assumed in the model that cells are equitably distributed to the two fragments via binary fission, either of the fragments could be purged as the planarian tumors of Dugesia etrusca and Dugesia ilvana are usually located at the posterior tip of the body (Lange 1966). As a result of the transverse fission, the progeny developed from the anterior fragment was not afflicted by the parental tumor (Lange 1966), reminiscent of fragmentational purging. In this case, the FRPG‐FR model assuming f1>f3 for the anterior fragment would be suitable to describe the evolutionary dynamics of those planarians.

Though comprehensive data is not available, I examined the cancer prevalence and regeneration capability of diverse animal (Metazoa) taxa which perform fragmentation after maturation. Intriguingly, while cancer is a prevailing disease among the wide range of animal taxa (Aktipis et al. 2015), there is no evidence of spontaneous cancer under natural conditions in some fissiparous or budding animals including starfish, sea anemone, and acorn worms (Table S1). It is also noteworthy that sponges and placozoans do not develop tumors even after exposure to high radiation (Fortunato et al. 2021, 2025). On the other hand, planarians, Hydra, corals, and brittle stars are susceptible to cancer though they perform fragmentation (Aktipis et al. 2015).

The proposed model can provide a possible explanation for different degrees of cancer susceptibility in fragmentational animals depending on cell replication number and degree of vertical cancer transmission rates which are quantitatively measurable (Tissot et al. 2024; Domazet‐Lošo et al. 2014). Cancer‐suppression capability (I in Equations (11), (12)) can be investigated as well. For example, many animals in which no sign of cancer was reported such as starfish (Kicha et al. 2010), sponges (Calcabrini et al. 2017), annelids (Macedo et al. 2021), sea anemones (Soletti et al. 2008) produce diverse anticancer substances.

Obviously, the absence of reports on cancer could be the consequence of insufficient observation: subsequent investigation may identify the naturally occurring tumors in those animals that are reportedly cancer‐resistant. Interspecific variation complicates the generalization of the relationship between fragmentation and cancer susceptibility. Further investigation is required to clarify how modes of reproduction influence the evolution of cancer (Table 2).

TABLE 2.

Future research questions.

Do animals that can perform fragmentation or budding have adult primordial stem cells (APSCs)?
Are fissiparous animals generally robust against cancer?
What is the required number of cell replications after fragmentation compared to the unitary development?
How much of the parental cancer cells are included in the fragment for asexual reproduction?
Are APSCs heavily protected from mutation (compared to somatic bystander cells)?
Does mutation in APSCs lead to carcinogenesis in fragmentational animals?
Does possession of APSCs inhibit a higher degree of differentiation across animal taxa?

The high degree of differentiation ensuring diverse cell types may not reliably coincide with the multipotency of the adult cells including the capability to dedifferentiate (epimorphosis) or transdifferentiate (morphallaxis) (Cho et al. 2024). Corroborating to this speculation, the organisms that can perform fragmentation up to date exhibit relatively simple body plans composed of a minor number of cell types (Table S1). Namely, possession of APSCs at the cost of sophisticated cell differentiation could be a suitable strategy for certain animals.

Extensive differentiation requires elaborate developmental mechanisms, the mutation at which would impose oncogenic transformation (cell specialization trade‐offs sensu Hammarlund et al. (2020)). As the number of the molecular pathways of the cells that control the proliferation and development increases, the risk of oncogenic mutations at either of those pathways would accordingly increase (Jacques et al. 2022). If all highly differentiated somatic cells are endowed with multipotency including transdifferentiation or dedifferentiation, one may speculate that the risk of cancer will dramatically escalate (Cho et al. 2024; Jacques et al. 2022). This would be the reason that animals with complex body plans are incapable of performing fragmentation and their regenerative capability is limited. Polypodium hydriforme could be an example of such a trade‐off between differentiation and regeneration (Table S1). Compared to other cnidarians, P. hydriforme has highly differentiated cell types (Raikova 2008). Though P. hydriforme can reproduce by fission, this animal does not exhibit remarkable regeneration (Raikova 2008).

To my knowledge, this is the first analytical model that investigates the link between asexual reproduction via fragmentation and evolutionary dynamics of cancer susceptibility by incorporating the number of cell replications, influence of APSCs, and vertical transmission extent of cancer cells. This study demonstrates various evolutionary pathways that fragmentation can be selected for and the corresponding cancer prevalence. Further examination of fissiparous or budding animals would verify the validity of the proposed model (Table 2) and provide insights for medical applications.

Germ cells, stem cells, and cancer stem cells have multiple features in common, particularly under the perspective of germline multipotent programs. Regeneration, cell type diversification, and oncogenicity would be accordingly intertwined (Jacques et al. 2022). Mammals would have favored complex body plans including neural systems by releasing regeneration, while Hydra would have pursued regeneration and budding at the cost of highly specialized cells. This perspective enables us to appreciate cancer as the outcome of the evolutionary trade‐offs (Jacqueline et al. 2017).

Conflicts of Interest

The author declares no conflicts of interest.

Supporting information

Appendix S1.

EVA-18-e70111-s001.pdf (470.2KB, pdf)

Video S1. Results of FRPG‐FR model.

EVA-18-e70111-s008.gif (3.5MB, gif)

Video S2. Results of FRPG‐UD model.

EVA-18-e70111-s005.gif (1.9MB, gif)

Video S3. Results of FRAC‐FR model.

EVA-18-e70111-s006.gif (3.6MB, gif)

Video S4. Results of FRAC‐UD model.

EVA-18-e70111-s003.gif (2.4MB, gif)

Video S5. Results of BINF‐FRa model.

EVA-18-e70111-s007.gif (2.9MB, gif)

Video S6. Results of BINF‐FRb model.

EVA-18-e70111-s002.gif (3.2MB, gif)

Video S7. Results of BINF‐UD model.

EVA-18-e70111-s004.gif (1.7MB, gif)

Funding: J. C. was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. RS‐2024‐00337511, No. 2021R1A6A3A01086754).

Data Availability Statement

The code for performing the computational analysis in this study is provided in Zenodo: https://zenodo.org/records/12789477.

References

  1. Aktipis, A. C. , Boddy A. M., Jansen G., et al. 2015. “Cancer Across the Tree of Life: Cooperation and Cheating in Multicellularity.” Philosophical Transactions of the Royal Society, B: Biological Sciences 370: 20140219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Álvarez‐Campos, P. , García‐Castro H., Emili E., et al. 2024. “Annelid Adult Cell Type Diversity and Their Pluripotent Cellular Origins.” Nature Communications 15: 3194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Becks, L. , and Agrawal A. F.. 2012. “The Evolution of Sex Is Favoured During Adaptation to New Environments.” PLoS Biology 10: e1001317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Belov, K. 2011. “The Role of the Major Histocompatibility Complex in the Spread of Contagious Cancers.” Mammalian Genome 22: 83–90. [DOI] [PubMed] [Google Scholar]
  5. Boutry, J. , Buysse M., Tissot S., et al. 2023. “Spontaneously Occurring Tumors in Different Wild‐Derived Strains of Hydra.” Scientific Reports 13: 7449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Boutry, J. , Tissot S., Mekaoui N., et al. 2022. “Tumors Alter Life History Traits in the Freshwater Cnidarian, Hydra oligactis .” iScience 25, no. 10: 105034. 10.1016/j.isci.2022.105034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bürger, R. 1999. “Evolution of Genetic Variability and the Advantage of Sex and Recombination in Changing Environments.” Genetics 153: 1055–1069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Calcabrini, C. , Catanzaro E., Bishayee A., Turrini E., and Fimognari C.. 2017. “Marine Sponge Natural Products With Anticancer Potential: An Updated Review.” Marine Drugs 15: 310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cheung, T. H. , and Rando T. A.. 2013. “Molecular Regulation of Stem Cell Quiescence.” Nature Reviews Molecular Cell Biology 14: 329–340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cho, C. J. , Brown J. W., and Mills J. C.. 2024. “Origins of Cancer: Ain't It Just Mature Cells Misbehaving?” EMBO Journal 43: 2530–2551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Domazet‐Lošo, T. , Klimovich A., Anokhin B., et al. 2014. “Naturally Occurring Tumours in the Basal Metazoan Hydra .” Nature Communications 5: 1–8. [DOI] [PubMed] [Google Scholar]
  12. Doonan, J. H. , and Sablowski R.. 2010. “Walls Around Tumours—Why Plants Do Not Develop Cancer.” Nature Reviews Cancer 10: 794–802. [DOI] [PubMed] [Google Scholar]
  13. Fortunato, A. , Fleming A., Aktipis A., and Maley C. C.. 2021. “Upregulation of DNA Repair Genes and Cell Extrusion Underpin the Remarkable Radiation Resistance of Trichoplax adhaerens .” PLoS Biology 19: e3001471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fortunato, A. , Taylor J., Scirone J., Seyedi S., Aktipis A., and Maley C. C.. 2025. “ Tethya w ilhelma (Porifera) is Highly Resistant to Radiation Exposure and Possibly Cancer.” Biology (Basel) 14: 171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fujita, S. , Takahashi M., Kumano G., Kuranaga E., Miura M., and Nakajima Y. I.. 2023. “Distinct Stem‐Like Cell Populations Facilitate Functional Regeneration of the Cladonema Medusa Tentacle.” PLoS Biology 21: e3002435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Garcia‐Borja, E. , Siegl F., Mateu R., et al. 2024. “Critical Appraisal of the piRNA‐PIWI Axis in Cancer and Cancer Stem Cells.” Biomarker Research 12: 15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Grosberg, R. K. , and Strathmann R. R.. 1998. “One Cell, Two Cell, Red Cell, Blue Cell: The Persistence of a Unicellular Stage in Multicellular Life Histories.” Trends in Ecology & Evolution 13: 112–116. [DOI] [PubMed] [Google Scholar]
  18. Hammarlund, E. U. , Amend S. R., and Pienta K. J.. 2020. “The Issues With Tissues: The Wide Range of Cell Fate Separation Enables the Evolution of Multicellularity and Cancer.” Medical Oncology 37: 62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hulett, R. E. , Kimura J. O., Bolaños D. M., et al. 2023. “Acoel Single‐Cell Atlas Reveals Expression Dynamics and Heterogeneity of Adult Pluripotent Stem Cells.” Nature Communications 14: 2612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ivankovic, M. , Haneckova R., Thommen A., et al. 2019. “Model Systems for Regeneration: Planarians.” Development 146, no. 17: dev167684. 10.1242/dev.167684. [DOI] [PubMed] [Google Scholar]
  21. Jacqueline, C. , Biro P. A., Beckmann C., et al. 2017. “Cancer: A Disease at the Crossroads of Trade‐Offs.” Evolutionary Applications 10: 215–225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jacques, F. , Baratchart E., Pienta K. J., and Hammarlund E. U.. 2022. “Origin and Evolution of Animal Multicellularity in the Light of Phylogenomics and Cancer Genetics.” Medical Oncology 39: 160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Juliano, C. E. , Swartz S. Z., and Wessel G. M.. 2010. “A Conserved Germline Multipotency Program.” Development 137: 4113–4126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kauffman, H. M. , Myron Kauffman H., McBride M. A., et al. 2002. “Transplant Tumor Registry: Donor Related Malignancies.” Transplantation 74, no. 3: 358–362. 10.1097/00007890-200208150-00011. [DOI] [PubMed] [Google Scholar]
  25. Kicha, A. A. , Ivanchina N. V., Huong T. T. T., et al. 2010. “Two New Asterosaponins, Archasterosides A and B, From the Vietnamese Starfish Archaster t ypicus and Their Anticancer Properties.” Bioorganic & Medicinal Chemistry Letters 20: 3826–3830. [DOI] [PubMed] [Google Scholar]
  26. Knudson, A. G., Jr. 1971. “Mutation and Cancer: Statistical Study of Retinoblastoma.” Proceedings of the National Academy of Sciences 68: 820–823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Konishi, H. , Mohseni M., Tamaki A., et al. 2011. “Mutation of a Single Allele of the Cancer Susceptibility Gene BRCA1 Leads to Genomic Instability in Human Breast Epithelial Cells.” Proceedings of the National Academy of Sciences 108: 17773–17778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lange, C. S. 1966. “Observations on Some Tumours Found in Two Species of Planaria—Dugesia etrusca and D. ilvana .” Development 15: 125–130. [PubMed] [Google Scholar]
  29. López‐Nandam, E. H. , Albright R., Hanson E. A., Sheets E. A., and Palumbi S. R.. 2023. “Mutations in Coral Soma and Sperm Imply Lifelong Stem Cell Renewal and Cell Lineage Selection.” Proceedings of the Royal Society B: Biological Sciences 290: 20221766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Macedo, M. W. F. S. , Cunha N. B., Carneiro J. A., et al. 2021. “Marine Organisms as a Rich Source of Biologically Active Peptides.” Frontiers in Marine Science 8: 667764. [Google Scholar]
  31. Magalhães, F. , Andrade C., Simões B., et al. 2023. “Regeneration of Starfish Radial Nerve Cord Restores Animal Mobility and Unveils a New Coelomocyte Population.” Cell and Tissue Research 394: 293–308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Masters, J. R. 2002. “HeLa Cells 50 Years on: The Good, the Bad and the Ugly.” Nature Reviews Cancer 2: 315–319. [DOI] [PubMed] [Google Scholar]
  33. Mihaylova, Y. , Abnave P., Kao D., et al. 2018. “Conservation of Epigenetic Regulation by the MLL3/4 Tumour Suppressor in Planarian Pluripotent Stem Cells.” Nature Communications 9: 3633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Miramón‐Puértolas, P. , Pascual‐Carreras E., and Steinmetz P. R. H.. 2024. “A Population of Vasa2 and Piwi1 Expressing Cells Generates Germ Cells and Neurons in a Sea Anemone.” Nature Communications 15: 8765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Muller, H. J. 1964. “The Relation of Recombination to Mutational Advance.” Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis 1: 2–9. [DOI] [PubMed] [Google Scholar]
  36. Pearse, A.‐M. , and Swift K.. 2006. “Transmission of Devil Facial‐Tumour Disease.” Nature 439: 549. [DOI] [PubMed] [Google Scholar]
  37. Queller, D. C. 2000. “Relatedness and the Fraternal Major Transitions.” Philosophical Transactions of the Royal Society, B: Biological Sciences 355: 1647–1655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Raikova, E. V. 2008. “Cytomorphological Peculiarities of Polypodium hydriforme (Cnidaria).” Journal of the Marine Biological Association of the United Kingdom 88: 1695–1702. [Google Scholar]
  39. Ratajczak, M. Z. , Bujko K., Mack A., Kucia M., and Ratajczak J.. 2018. “Cancer From the Perspective of Stem Cells and Misappropriated Tissue Regeneration Mechanisms.” Leukemia 32: 2519–2526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Shackleton, M. , Quintana E., Fearon E. R., and Morrison S. J.. 2009. “Heterogeneity in Cancer: Cancer Stem Cells Versus Clonal Evolution.” Cell 138: 822–829. [DOI] [PubMed] [Google Scholar]
  41. Smilenov, L. B. 2006. “Tumor Development: Haploinsufficiency and Local Network Assembly.” Cancer Letters 240: 17–28. [DOI] [PubMed] [Google Scholar]
  42. Solana, J. 2013. “Closing the Circle of Germline and Stem Cells: The Primordial Stem Cell Hypothesis.” EvoDevo 4: 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Soletti, R. C. , de Faria G. P., Vernal J., et al. 2008. “Potentiation of Anticancer‐Drug Cytotoxicity by Sea Anemone Pore‐Forming Proteins in Human Glioblastoma Cells.” Anti‐Cancer Drugs 19: 517–525. [DOI] [PubMed] [Google Scholar]
  44. Stocchino, G. A. , and Manconi R.. 2013. “Overview of Life Cycles in Model Species of the Genus Dugesia (Platyhelminthes: Tricladida).” Italian Journal of Zoology 80: 319–328. [Google Scholar]
  45. Thomas, F. , Madsen T., Giraudeau M., et al. 2019. “Transmissible Cancer and the Evolution of Sex.” PLoS Biology 17: e3000275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Tissot, S. , Meliani J., Boutry J., et al. 2024. “De Novo Evolution of Transmissible Tumours in Hydra.” Proceedings of the Royal Society B 291: 20241636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Tolar, J. , and Neglia J. P.. 2003. “Transplacental and Other Routes of Cancer Transmission Between Individuals.” Journal of Pediatric Hematology/Oncology 25: 430–434. [DOI] [PubMed] [Google Scholar]
  48. Tomasetti, C. , and Vogelstein B.. 2015. “Variation in Cancer Risk Among Tissues Can Be Explained by the Number of Stem Cell Divisions.” Science 347: 78–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Tyner, S. D. , Venkatachalam S., Choi J., et al. 2002. “p53 Mutant Mice That Display Early Ageing‐Associated Phenotypes.” Nature 415: 45–53. [DOI] [PubMed] [Google Scholar]
  50. Ujvari, B. , Gatenby R. A., and Thomas F.. 2016. “The Evolutionary Ecology of Transmissible Cancers.” Infection, Genetics and Evolution 39: 293–303. [DOI] [PubMed] [Google Scholar]
  51. Vakhrusheva, O. A. , Mnatsakanova E. A., Galimov Y. R., et al. 2020. “Genomic Signatures of Recombination in a Natural Population of the Bdelloid Rotifer Adineta vaga .” Nature Communications 11: 6421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Van Roten, A. , Barakat A. Z. A., Wouters A., et al. 2018. “A Carcinogenic Trigger to Study the Function of Tumor Suppressor Genes in Schmidtea mediterranea .” Disease Models & Mechanisms 11: dmm032573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Voura, E. B. , Montalvo M. J., dela Roca K. T., et al. 2017. “Planarians as Models of Cadmium‐Induced Neoplasia Provide Measurable Benchmarks for Mechanistic Studies.” Ecotoxicology and Environmental Safety 142: 544–554. [DOI] [PubMed] [Google Scholar]
  54. Zayas, R. M. , Hernández A., Habermann B., Wang Y., Stary J. M., and Newmark P. A.. 2005. “The Planarian Schmidtea mediterranea as a Model for Epigenetic Germ Cell Specification: Analysis of ESTs From the Hermaphroditic Strain.” Proceedings of the National Academy of Sciences 102: 18491–18496. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Appendix S1.

EVA-18-e70111-s001.pdf (470.2KB, pdf)

Video S1. Results of FRPG‐FR model.

EVA-18-e70111-s008.gif (3.5MB, gif)

Video S2. Results of FRPG‐UD model.

EVA-18-e70111-s005.gif (1.9MB, gif)

Video S3. Results of FRAC‐FR model.

EVA-18-e70111-s006.gif (3.6MB, gif)

Video S4. Results of FRAC‐UD model.

EVA-18-e70111-s003.gif (2.4MB, gif)

Video S5. Results of BINF‐FRa model.

EVA-18-e70111-s007.gif (2.9MB, gif)

Video S6. Results of BINF‐FRb model.

EVA-18-e70111-s002.gif (3.2MB, gif)

Video S7. Results of BINF‐UD model.

EVA-18-e70111-s004.gif (1.7MB, gif)

Data Availability Statement

The code for performing the computational analysis in this study is provided in Zenodo: https://zenodo.org/records/12789477.


Articles from Evolutionary Applications are provided here courtesy of Wiley

RESOURCES